For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Summit Therapeutics Inc (NASDAQ: SMMT) was $17.47 for the day, down -4.22% from the previous closing price of $18.24. In other words, the price has decreased by -$4.22 from its previous closing price. On the day, 2.07 million shares were traded. SMMT stock price reached its highest trading level at $18.51 during the session, while it also had its lowest trading level at $17.41.
Ratios:
Our analysis of SMMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.31 and its Current Ratio is at 8.31. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on December 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $30.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $31.
On November 04, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $32.JMP Securities initiated its Mkt Outperform rating on November 04, 2024, with a $32 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 30,000 shares of SMMT for $112,500 on Mar 26 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $3.75 per share. On Mar 27 ’24, another insider, Zanganeh Mahkam, who serves as the Chief Executive Officer of the company, bought 26,000 shares for $3.72 each. As a result, the insider paid 96,720 and bolstered with 520,814 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 12883216384 and an Enterprise Value of 12428821504.
Stock Price History:
The Beta on a monthly basis for SMMT is -0.89, which has changed by 4.9607844 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, SMMT has reached a high of $33.89, while it has fallen to a 52-week low of $2.10. The 50-Day Moving Average of the stock is -8.23%, while the 200-Day Moving Average is calculated to be 36.93%.
Shares Statistics:
SMMT traded an average of 2.28M shares per day over the past three months and 2325160 shares per day over the past ten days. A total of 737.09M shares are outstanding, with a floating share count of 114.59M. Insiders hold about 84.45% of the company’s shares, while institutions hold 11.50% stake in the company. Shares short for SMMT as of 1734048000 were 17529194 with a Short Ratio of 7.68, compared to 1731628800 on 15987477. Therefore, it implies a Short% of Shares Outstanding of 17529194 and a Short% of Float of 14.75.
